Long-term persistence of oligoclonal serum IgM repertoires in patients treated with allogeneic bone marrow transplantation (BMT)

Clinical and Experimental Immunology

Volumn 119, Issue 1, 2000, Pages 240-249

  Nasman Bjork I ^a,g   Brissac, C ^b   Remberger, M ^a   Mattsson, J ^a,c,d   Klaesson, S ^c,e   Ringden O ^a,c,d   Stewart, J ^f   Lundkvist, I ^a,e  

^a Division of Clinical Immunology   (Sweden)

^b INSTITUT PASTEUR   (France)

^c Bone Marrow Transplantation Unit   (Sweden)

^d Dept of Transplantation Surgery ^*  (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibodies; Generation of diversity; Human; Repertoire development; Transplantation

Indexed keywords

HLA ANTIGEN; IMMUNOGLOBULIN M;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; GENE REARRANGEMENT; GENETIC VARIABILITY; GRAFT SURVIVAL; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; ANTIBODY DIVERSITY; BONE MARROW TRANSPLANTATION; CASE-CONTROL STUDIES; GRAFT SURVIVAL; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIVING DONORS; MIDDLE AGED; NUCLEAR FAMILY; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033964917     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01118.x     Document Type: Article

References (30)

1. 1 Näsman I, Lundkvist I. Evidence for oligoclonal diversification of the VH6-containing immunoglobulin repertoire during reconstitution after bone marrow transplantation. Blood 1996; 87:2795-804.
2. 2 Näsman-Björk I, Lundkvist I. Oligoclonal dominance of immunoglobulin VH3 rearrangements following allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 21:1223-30.
3. 3 Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987; 69:369-80.
4. 4 Kagan JM, Champlin RE, Saxon A. B-cell dysfunction following human bone marrow transplantation: functional-phenotypic dissociation in the early posttransplant period. Blood 1989; 74:777-85.
5. 5 Storek J, Saxon A. Reconstitution of B cell immunity following bone marrow transplantation. Bone Marrow Transplant 1992; 9:395-408.
6. 6 Lum LG. Immune recovery after bone marrow transplantation. Hematol Oncol Clin North Am 1990; 4:659-75.
7. 7 Nobrega A, Haury M, Grandien A, Malanchère E, Sundblad A, Coutinho A. Global analysis of antibody repertoires. II. Evidence for specificity, self-selection and the immunological 'homunculus' of antibodies in normal serum. Eur J Immunol 1993; 23:2851-9.
8. 8 Haury M, Grandien A, Sundblad A, Coutinho A, Nobrega A. Global analysis of antibody repertoires. I. An immunoblot method for the quantitative screening of large numbers of reactivities. Scand J Immunol 1994; 39:79-87.
9. 9 Brissac C, Nobrega A, Carneiro J, Stewart J. Functional diversity of natural IgM. Int Immunol 1999; 11:1501-7.
10. 10 Ringdén O, Pihlstedt P, Markling L et al. Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients. Bone Marrow Transplant 1991; 7:221-6.
11. 11 Klaesson S, Ringdén O, Ljungman P, Aschan JH, Hägglund H, Winiarski J. Increased mortality in veno-occlusive disease of the liver in bone marrow transplanted recipients treated with intravenous immune globulin. Transplantation 1995; 60:1225-30.
12. 12 Hurez V, Kazatchkine MD, Vassilev T et al. Pooled normal human polyspecific IgM contains neutralizing anti-idiotypes to IgG autoanti-bodies of autoimmune patients and protects from experimental auto-immune disease. Blood 1997; 90:4004-13.
13. 13 Berek C, Milstein C. The dynamic nature of the antibody repertoire. Immunol Rev 1988; 105:5-26.
14. 14 Suzuki I, Milner EC, Glas AM et al. Immunoglobulin heavy chain variable region gene usage in bone marrow transplant recipients: lack of somatic mutation indicates a maturational arrest. Blood 1996; 87:1873-80.
15. 15 Storek J, Witherspoon RP, Storb R. Reconstitution of membrane IgD-(mIgD-) B cells after marrow transplantation lags behind the reconstitution of mIgD+ B cells. Blood 1997; 89:350-1.
16. 16 Han S, Zheng B, Schatz DG, Spanopoulou E, Kelsoe G. Neoteny in lymphocytes: Rag 1 and Rag 2 expression in germinal center B cells. Science 1996; 274:2094-7.
17. 17 Hikida M, Mori M, Takai T, Tomochika K, Hamatani K, Ohmori H. Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells. Science 1996; 274:2092-4.
18. 18 Han S, Dillon SR, Zheng B, Shimoda M, Schlissel M, Kelsoe G. V(D)J recombinase activity in a subset of germinal center B lymphocytes. Science 1997; 278:301-5.
19. 19 Papavasiliou F, Casellas R, Suh H et al. V(D)J recombination in mature B cells: a mechanism for altering antibody responses. Science 1997; 278:298-301.
20. 20 Agenès F, Rosado MM, Freitas AA. Independent homeostatic regulation of B cell compartments. Eur J Immunol 1997; 27:1801-7.
21. 21 Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990; 5:209-26.
22. 22 Roux E, Helg C, Dumont-Girard F, Chapuis B, Jeannet M, Roosnek E. Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts. Blood 1996; 87:3984-92.
23. 23 Gerritsen EJ, Van Tol MJ, Van 't Veer MB et al. Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation. Blood 1994; 84:4374-82.
24. 24 Ljungman P, Wiklund-Hammarsten M, Duraj V et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 1990; 162:496-500.
25. 25 Hammarström V, Pauksen K, Svensson H et al. Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients. Transplantation 1998; accepted for publication.
26. 26 Mackall CL, Gress RE. Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol Rev 1997; 157:61-72.
27. 27 Parkman R, Weinberg KI. Immunological reconstitution following bone marrow transplantation. Immunol Rev 1997; 157:73-8.
28. 28 Small TN, Avigan D, Dupont B et al. Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and post-transplant graft rejection prophylaxis. Biol Blood Marrow Transplant 1997; 3:65-75.
29. 29 Ochs L, Xiao OS, Miller J et al. Late infections after allogeneic bone marrow transplantation: comparison of incidence in related and unrelated donor transplant recipients. Blood 1995; 86:3979-86.
30. 30 Ringdén O. Bone marrow transplantation using unrelated donors for haematological malignancies. Med Oncol 1997; 14:11-22.